Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-06-03

FDA Approved: NITHIODOTE — Supplemental Application (Hope Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for NITHIODOTE, a combination of sodium nitrite and sodium thiosulfate, from Hope Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NITHIODOTE (Sodium nitrite and sodium thiosulfate)

Snippet

SUPPL AP for NITHIODOTE (SODIUM NITRITE AND SODIUM THIOSULFATE)